Written by The Veterinary Antimicrobial Susceptibility Testing Market has become an essential component of modern veterinary diagnostics as antimicrobial resistance continues to emerge as one of the world’s most pressing public health concerns. Veterinary antimicrobial susceptibility testing enables laboratories and veterinarians to determine the effectiveness of antimicrobial agents against bacterial pathogens before initiating treatment. This scientific approach supports evidence-based antimicrobial selection, minimizes inappropriate antibiotic usage, improves clinical outcomes, and contributes significantly toward global antimicrobial stewardship initiatives.
👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=83264
Growing awareness regarding responsible antibiotic administration has substantially transformed veterinary healthcare practices over the past decade. Regulatory agencies, animal healthcare organizations, livestock producers, and veterinary professionals increasingly recognize susceptibility testing as a necessary step in preventing the spread of resistant bacterial strains among both food-producing and companion animals. The rising frequency of zoonotic infections further strengthens demand for advanced veterinary diagnostic technologies capable of providing accurate antimicrobial resistance profiling.
Market Size and Growth
The Veterinary Antimicrobial Susceptibility Testing Market generated approximately US$ 37.6 Billion in 2021 and is estimated to reach US$ 40.0 Billion in 2022. Supported by increasing investments in veterinary diagnostics, stronger regulatory oversight, and growing awareness regarding antimicrobial resistance, the market is projected to expand at a 6.7% CAGR throughout the forecast period, ultimately reaching US$ 76.2 Billion by 2032.
Historically, the market demonstrated stable performance, recording a CAGR of approximately 6.0% between 2017 and 2021. During this period, increasing livestock production, rising antimicrobial consumption, and expanding veterinary healthcare services significantly contributed to sustained demand for susceptibility testing products.
Future market growth is expected to be driven by automation technologies, rapid diagnostic platforms, laboratory standardization, expanding surveillance programs, increasing pet insurance penetration, and government-supported antimicrobial stewardship initiatives. Continuous improvements in laboratory efficiency and faster turnaround times are expected to further accelerate market adoption globally.
Market Segmentation
By Product Type
The market is segmented into Disks & Plates, Culture Media, and Accessories & Consumables. Disks and plates remain the most widely utilized products due to their standardized application across veterinary laboratories. Culture media continue to experience stable demand as bacterial isolation remains an essential step in susceptibility testing workflows. Meanwhile, accessories and consumables represent a recurring revenue stream supported by growing testing volumes worldwide.
By Animal Type
The Veterinary Antimicrobial Susceptibility Testing Market serves both Livestock Animals and Companion Animals.
Livestock animals—including cattle, poultry, pigs, and other production animals—account for a substantial market share owing to increasing global demand for meat, milk, eggs, and other animal-derived food products. Responsible antimicrobial usage in livestock production has become a major regulatory priority, driving greater adoption of susceptibility testing.
Companion animals—including dogs, cats, horses, and other pets—represent a rapidly growing segment as pet owners increasingly seek advanced diagnostic services and personalized veterinary treatments. Rising disposable incomes and expanding pet insurance coverage continue supporting diagnostic testing demand across developed and emerging markets alike.
By End Use
Veterinary Reference Laboratories dominate the market due to their advanced diagnostic capabilities, standardized testing methodologies, and growing sample volumes received from veterinary clinics and hospitals. Veterinary Research Institutes also contribute significantly by supporting antimicrobial resistance surveillance, academic research, and development of standardized testing protocols. Additional end users include government laboratories and specialized diagnostic centers.
Regional Analysis
North America continues to lead the Veterinary Antimicrobial Susceptibility Testing Market, supported by high veterinary healthcare expenditure, increasing companion animal ownership, advanced laboratory infrastructure, and strong regulatory oversight. The United States remains the largest contributor, with the market expected to reach approximately US$ 20 Billion by 2032.
Europe represents another mature regional market driven by stringent antimicrobial stewardship regulations and proactive government initiatives aimed at reducing routine antibiotic use in livestock farming. New European regulations restricting prophylactic antibiotic usage continue supporting long-term market expansion.
Asia-Pacific is anticipated to witness the fastest growth throughout the forecast period. Rapid urbanization, increasing disposable incomes, expanding livestock populations, growing companion animal adoption, and improving veterinary healthcare infrastructure across China, India, Japan, and South Korea continue creating substantial market opportunities.
Latin America and the Middle East & Africa are also expected to experience steady growth owing to modernization of veterinary services, increasing awareness of antimicrobial resistance, and expanding livestock industries.
Competitive Landscape
The Veterinary Antimicrobial Susceptibility Testing Market remains moderately consolidated with several multinational diagnostic companies investing heavily in innovation, strategic partnerships, acquisitions, and laboratory automation technologies.
Major market participants include BioMĂ©rieux SA, Becton Dickinson and Company, Synbiosis, Thermo Fisher Scientific, Bruker Corporation, Danaher Corporation, Condalab, Bioguard Corporation, Liofilchem S.r.l., HiMedia Laboratories, Bio-Rad Laboratories, Neogen Corporation, Merck KGaA, MERLIN Diagnostika GmbH, Accelerate Diagnostics Inc., Alifax S.r.l., Creative Diagnostics, and Zhuhai DL Biotech Co. Ltd.
Recent developments illustrate the industry’s commitment to innovation. Neogen Corporation expanded its companion animal diagnostics portfolio through the acquisition of Genetic Veterinary Sciences. Becton Dickinson continues supporting antimicrobial resistance management globally through collaborations focused on strengthening laboratory capabilities in low- and middle-income countries.
Companies are increasingly prioritizing rapid diagnostics, automated susceptibility testing platforms, digital laboratory workflows, artificial intelligence integration, and standardized antimicrobial resistance surveillance solutions to strengthen competitive positioning over the coming decade.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Media Contact:Â
Abhishek Budholiya
Transparency Market Research Inc.
State Tower, 90 State Street, Suite 700,
Albany NY – 12207, United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453